Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Q2 2025 Earnings Call Transcript July 31, 2025
Agios Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-1.93 EPS, expectations were $-1.74.
Operator: Good morning, and welcome to Agios’ Second Quarter 2025 Conference Call. [Operator Instructions] Please be advised that this call is being recorded at Agios’s request. I would now like to turn the call over to Agio. Please go ahead.
Morgan Sanford: Thank you, operator. Good...
